![Effect of Combining Traditional Chinese Medicine with Hormonal Therapy on Quality of Life and Tumor Markers of Prostate Cancer Patients Effect of Combining Traditional Chinese Medicine with Hormonal Therapy on Quality of Life and Tumor Markers of Prostate Cancer Patients](https://static-02.hindawi.com/articles/ecam/volume-2021/5061867/figures/5061867.fig.001.jpg)
Effect of Combining Traditional Chinese Medicine with Hormonal Therapy on Quality of Life and Tumor Markers of Prostate Cancer Patients
![Quality of life in patients with prostate cancer: development and application of a hybrid assessment method | Prostate Cancer and Prostatic Diseases Quality of life in patients with prostate cancer: development and application of a hybrid assessment method | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2008.28/MediaObjects/41391_2009_Article_BFpcan200828_Fig3_HTML.jpg)
Quality of life in patients with prostate cancer: development and application of a hybrid assessment method | Prostate Cancer and Prostatic Diseases
![PDF) The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version PDF) The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version](https://www.researchgate.net/profile/Han-Choi-3/publication/7164756/figure/tbl3/AS:202563233292299@1425306246227/Test-retest-reliability-of-the-Korean-FACT-P-using-intraclass-correlation-coefficients_Q320.jpg)
PDF) The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version
![PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/17df96d4977b56c8f591ea961b984aebbe19cd7e/3-Table2-1.png)
PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar
![Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems” | SpringerLink Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems” | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11136-019-02316-4/MediaObjects/11136_2019_2316_Fig1_HTML.png)
Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems” | SpringerLink
![Table 2 from Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. | Semantic Scholar Table 2 from Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fe1aa392abe04d0c1bc2101db26368c321a5e1e2/5-Table3-1.png)
Table 2 from Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. | Semantic Scholar
![PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/17df96d4977b56c8f591ea961b984aebbe19cd7e/3-Table4-1.png)
PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar
![Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy - ScienceDirect Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491300720X-gr3.jpg)
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy - ScienceDirect
![PDF) The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version PDF) The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version](https://i1.rgstatic.net/publication/7164756_The_Functional_Assessment_of_Cancer_Therapy-Prostate_FACT-P_Scales_in_Men_with_Prostate_Cancer_Reliability_and_Validity_of_the_Korean_Version/links/0fcfd50ef477ac0e6b000000/largepreview.png)
PDF) The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version
![ASCO GU 2020: (CARD) Pain Response and Health-Related Quality of Life Analysis in Patients with Metastatic Castration-Resistant Prostate Cancer ASCO GU 2020: (CARD) Pain Response and Health-Related Quality of Life Analysis in Patients with Metastatic Castration-Resistant Prostate Cancer](https://www.urotoday.com/images/ASCOGU20_FACT-P.png)
ASCO GU 2020: (CARD) Pain Response and Health-Related Quality of Life Analysis in Patients with Metastatic Castration-Resistant Prostate Cancer
![A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients | Health and Quality of Life Outcomes A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients | Health and Quality of Life Outcomes](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-018-0870-6/MediaObjects/12955_2018_870_Fig1_HTML.gif)
A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients | Health and Quality of Life Outcomes
![Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer | SpringerLink Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-019-01157-4/MediaObjects/12325_2019_1157_Fig2_HTML.png)
Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer | SpringerLink
![Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study | Radiation Oncology | Full Text Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-022-02061-y/MediaObjects/13014_2022_2061_Fig2_HTML.png)
Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study | Radiation Oncology | Full Text
![1 Chapter 8 Quality of Life Assessment. 2 News 乳癌的標靶治療用藥有了新突破!國內台大、 榮總、三總、馬偕、奇美、高醫、彰基等醫學中心現正著手進行乳癌新藥 1 Chapter 8 Quality of Life Assessment. 2 News 乳癌的標靶治療用藥有了新突破!國內台大、 榮總、三總、馬偕、奇美、高醫、彰基等醫學中心現正著手進行乳癌新藥](https://images.slideplayer.com/32/9974814/slides/slide_47.jpg)
1 Chapter 8 Quality of Life Assessment. 2 News 乳癌的標靶治療用藥有了新突破!國內台大、 榮總、三總、馬偕、奇美、高醫、彰基等醫學中心現正著手進行乳癌新藥
![PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/17df96d4977b56c8f591ea961b984aebbe19cd7e/2-Table1-1.png)
PDF] The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version | Semantic Scholar
![Quality of life in patients with prostate cancer: development and application of a hybrid assessment method | Prostate Cancer and Prostatic Diseases Quality of life in patients with prostate cancer: development and application of a hybrid assessment method | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2008.28/MediaObjects/41391_2009_Article_BFpcan200828_Fig2_HTML.gif)
Quality of life in patients with prostate cancer: development and application of a hybrid assessment method | Prostate Cancer and Prostatic Diseases
![Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421) | Journal of Patient-Reported Outcomes Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421) | Journal of Patient-Reported Outcomes](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41687-018-0054-5/MediaObjects/41687_2018_54_Fig3_HTML.png)